Literature DB >> 2189011

Pertussis in an adult man infected with the human immunodeficiency virus.

B N Doebbeling1, M L Feilmeier, L A Herwaldt.   

Abstract

A 25-year-old man infected with the human immunodeficiency virus (HIV) presented with paroxysmal cough and dyspnea of 4-months duration. An extensive evaluation including bronchoscopy was negative. A nasopharyngeal swab was positive by direct fluorescent antigen detection and culture for Bordetella pertussis. Respiratory isolation, treatment with erythromycin, and prophylaxis of household contacts was used to eradicate the organism and prevent transmission. Pertussis should be considered as a cause of prolonged cough and dyspnea in patients with HIV infection. The course of this patient was consistent with the concept that cell-mediated immunity is necessary for elimination of B. pertussis.

Entities:  

Mesh:

Year:  1990        PMID: 2189011     DOI: 10.1093/infdis/161.6.1296

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Bordetella pertussis versus non-L. pneumophila Legionella spp.: a continuing diagnostic challenge.

Authors:  V Ng; L Weir; M K York; W K Hadley
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Brief Report: Seroprevalence of Pertussis Infection in HIV-Infected Adults in the United States.

Authors:  Stephanie B Troy; Alexandria E-B Rossheim; DaShaunda D Hilliard; Tina D Cunningham
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

3.  Bacteremia caused by a novel Bordetella species, "B. hinzii".

Authors:  B T Cookson; P Vandamme; L C Carlson; A M Larson; J V Sheffield; K Kersters; D H Spach
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

4.  Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project.

Authors:  Rulin C Hechter; Lei Qian; Sara Y Tartof; Lina S Sy; Nicola P Klein; Eric Weintraub; Cheryl Mercado; Allison Naleway; Huong Q McLean; Steven J Jacobsen
Journal:  Vaccine       Date:  2019-05-04       Impact factor: 3.641

5.  A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.

Authors:  Ciaran M Skerry; Joseph P Cassidy; Karen English; Pascal Feunou-Feunou; Camille Locht; Bernard P Mahon
Journal:  Clin Vaccine Immunol       Date:  2009-07-22

6.  Identification of Bordetella pertussis in a critically ill human immunodeficiency virus-infected patient by direct genotypical analysis of Gram-stained material and discrimination from B. holmesii by using a unique recA gene restriction enzyme site.

Authors:  Ole Vielemeyer; Jill Y Crouch; Stephen C Edberg; John G Howe
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

7.  Seroprevalence of pertussis antibody among health care personnel in Spain.

Authors:  Jose-Ramón de Juanes; Angel Gil; Antonio González; María-Pilar Arrazola; María San-Martín; Jesús Esteban
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

8.  Bordetella pertussis as a cause of chronic respiratory infection in an AIDS patient.

Authors:  R Colebunders; C Vael; K Blot; J Van Meerbeeck; J Van den Ende; M Ieven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-04       Impact factor: 3.267

9.  Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa.

Authors:  Mathurin C Tejiokem; Elisabeth Njamkepo; Ionela Gouandjika; Dominique Rousset; Lydie Béniguel; Catherine Bilong; Gilbert Tene; Ida Penda; Carine Ngongueu; Jean C Gody; Nicole Guiso; Laurence Baril
Journal:  Clin Vaccine Immunol       Date:  2009-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.